 |
|
CLINICIAN'S CORNER
Small Intestinal Bacterial Overgrowth
A Framework for Understanding Irritable Bowel Syndrome
Henry C. Lin, MD
JAMA. 2004;292:852-858.
Context Irritable bowel syndrome (IBS), which affects 11% to 14% of the population, is a puzzling condition with multiple models of pathophysiology including altered motility, visceral hypersensitivity, abnormal brain-gut interaction, autonomic dysfunction, and immune activation. Although no conceptual framework accounts for all the symptoms and observations in IBS, a unifying explanation may exist since 92% of these patients share the symptom of bloating regardless of their predominant complaint.
Evidence Acquisition Ovid MEDLINE was searched through May 2004 for relevant English-language articles beginning with those related to bloating, gas, and IBS. Bibliographies of pertinent articles and books were also scanned for additional suitable citations.
Evidence Synthesis The possibility that small intestinal bacterial overgrowth (SIBO) may explain bloating in IBS is supported by greater total hydrogen excretion after lactulose ingestion, a correlation between the pattern of bowel movement and the type of excreted gas, a prevalence of abnormal lactulose breath test in 84% of IBS patients, and a 75% improvement of IBS symptoms after eradication of SIBO. Altered gastrointestinal motility and sensation, changed activity of the central nervous system, and increased sympathetic drive and immune activation may be understood as consequences of the host response to SIBO.
Conclusions The gastrointestinal and immune effects of SIBO provide a possible unifying framework for understanding frequent observations in IBS, including postprandial bloating and distension, altered motility, visceral hypersensitivity, abnormal brain-gut interaction, autonomic dysfunction, and immune activation.
Author Affiliation: Division of Gastrointestinal and Liver Diseases, Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles.
RELATED LETTER
Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome
Timothy King
JAMA. 2004;292(18):2213.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
The small intestinal bacterial overgrowth. Irritable bowel syndrome hypothesis: implications for treatment
Vanner
Gut 2008;57:1315-1321.
FULL TEXT
Altered intestinal permeability in patients with primary fibromyalgia and in patients with complex regional pain syndrome
Goebel et al.
Rheumatology (Oxford) 2008;47:1223-1227.
ABSTRACT
| FULL TEXT
Rifaximin Treatment for Symptoms of Irritable Bowel Syndrome
Fumi and Trexler
The Annals of Pharmacotherapy 2008;42:408-412.
ABSTRACT
| FULL TEXT
Update: A 54-Year-Old Woman With Constipation-Predominant Irritable Bowel Syndrome
Farag et al.
JAMA 2008;299:88-88.
FULL TEXT
Translating symptoms into mechanisms: functional GI disorders
Collins
Adv. Physiol. Educ. 2007;31:329-331.
ABSTRACT
| FULL TEXT
Probiotics in Irritable Bowel Syndrome: An Immunomodulatory Strategy?
Quigley
J. Am. Coll. Nutr. 2007;26:684S-690S.
ABSTRACT
| FULL TEXT
Synergy between Lactobacillus paracasei and Its Bacterial Products to Counteract Stress-Induced Gut Permeability and Sensitivity Increase in Rats
Eutamene et al.
J. Nutr. 2007;137:1901-1907.
ABSTRACT
| FULL TEXT
Evidence of Prolonged Orocecal Transit Time and Small Intestinal Bacterial Overgrowth in Acromegalic Patients
Resmini et al.
J. Clin. Endocrinol. Metab. 2007;92:2119-2124.
ABSTRACT
| FULL TEXT
Small intestinal bacterial overgrowth in patients with irritable bowel syndrome
Posserud et al.
Gut 2007;56:802-808.
ABSTRACT
| FULL TEXT
Treating Irritable Bowel Syndrome with a Food Elimination Diet Followed by Food Challenge and Probiotics
Drisko et al.
J. Am. Coll. Nutr. 2006;25:514-522.
ABSTRACT
| FULL TEXT
Treatment for bacterial overgrowth in the irritable bowel syndrome.
Drossman
ANN INTERN MED 2006;145:626-628.
FULL TEXT
A 54-Year-Old Woman With Constipation-Predominant Irritable Bowel Syndrome
Lembo
JAMA 2006;295:925-933.
FULL TEXT
Nutrition Aspects of Gastroparesis and Therapies for Drug-Refractory Patients
Abell et al.
Nutr Clin Pract 2006;21:23-33.
ABSTRACT
| FULL TEXT
Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome
King
JAMA 2004;292:2213-2213.
FULL TEXT
|
